Blog

Jun Gong: Podcast on mUC and how maintenance avelumab fits into the global 1L paradigm

A collage photo of Jun Gong and Melissa Reimers

Jul 23, 2024, 00:19

Jun Gong: Podcast on mUC and how maintenance avelumab fits into the global 1L paradigm

Jun Gong, Medical Oncologist and Researcher in Gastrointestinal and Genitourinary cancers at Cedars-Sinai, shared a post on X by EMD Serono adding:

“Was a delight doing this podcast with Melissa Reimers, Siteman Cancer Center and Washington University in St. Louis on mUC and how maintenance avelumab fits into the global 1L paradigm.

Published in: Springer Nature and Advances in Therapy.”

Quoting EMD Serono’s post below:

“Listen to two medical oncologists, Jun Gong and Melissa Reimers, as they provide their practical considerations in first-line treatments of patients with advanced urothelial carcinoma in this podcast.”

View the article attached to the post.
Sources: Jun Gong/X and EMD Serono/X

Advances in Therapy Avelumab cancer EMD Serono Jun Gong Melissa Reimers OncoDaily Oncology Siteman Cancer Center Springer Nature urothelial carcinoma Washington University in St. Louis

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage